PD-1/PD-L1 inhibitors increase risk of hepatitis

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-020-79793-1
中图分类号
学科分类号
摘要
引用
收藏
页码:9 / 9
相关论文
共 50 条
  • [1] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
  • [2] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    [J]. BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [3] PD-1/PD-L1 Inhibitors in Cervical Cancer
    Liu, Yuncong
    Wu, Li
    Tong, Ruizhan
    Yang, Feiyue
    Yin, Limei
    Li, Mengqian
    You, Liting
    Xue, Jianxin
    Lu, You
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [4] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    [J]. ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [5] Advances in pharmacokinetics and pharmacodynamics of PD-1/PD-L1 inhibitors
    Yan, Ting
    Yu, Lun
    Shangguan, Dangang
    Li, Wei
    Liu, Ni
    Chen, Yun
    Fu, Yilan
    Tang, Jingyi
    Liao, Dehua
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 115
  • [6] Ocular adverse events in PD-1 and PD-L1 inhibitors
    Young, LeAnne
    Finnigan, Shanda
    Streicher, Howard
    Chen, Helen X.
    Murray, James
    Sen, H. Nida
    Sharon, Elad
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [7] Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
    Ming Yi
    Dechao Jiao
    Hanxiao Xu
    Qian Liu
    Weiheng Zhao
    Xinwei Han
    Kongming Wu
    [J]. Molecular Cancer, 17
  • [8] Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
    Yi, Ming
    Jiao, Dechao
    Xu, Hanxiao
    Liu, Qian
    Zhao, Weiheng
    Han, Xinwei
    Wu, Kongming
    [J]. MOLECULAR CANCER, 2018, 17
  • [9] Progress on biphenyl derivatives as PD-1/PD-L1 inhibitors
    Wang, Shurong
    Wang, Yuli
    Yan, Hong
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (10) : 2089 - 2115
  • [10] Efficiency of PD-1 and PD-L1 Inhibitors in Malignant Therapy
    Gappa, Birgit
    Kobold, Sebastian
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (01) : 7 - 8